Torchlight Innovations Inc. (TSXV: TLX.P) (‘Torchlight’ or ‘the Company’), doing business as RZOLV Technologies, is pleased to announce positive preliminary results from its…
Category:
Investing
-
-
-
-
-
-
-
-
-
-
Investing
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
by adminMAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application…
